Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03242161
Other study ID # 2017P001502
Secondary ID
Status Recruiting
Phase Early Phase 1
First received
Last updated
Start date January 1, 2018
Est. completion date April 30, 2024

Study information

Verified date January 2024
Source Mclean Hospital
Contact Scott Lukas, PhD
Phone 617-855-2767
Email slukas@mclean.harvard.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to test LabPatch-alcohol, a wearable, non-invasive biosensor Band-Aid like patch that is designed to detect real-time changes in interstitial alcohol concentrations in human subjects. The changes in interstitial alcohol concentrations will be compared to blood alcohol concentrations to determine the patch's validity against the gold standard.


Description:

Nanotechnology has the potential to become a powerful tool in addiction medicine. The potential utility for passive, non-invasive wearable alcohol monitors is great and could play a major role in public safety as well as in both research, clinical, and treatment settings. Clinitech, LLC has developed LabPatch, an electronic bandage that continuously and imperceptibly samples interstitial fluid from the skin surface and measures relevant biomarkers in the fluid. The patch uses novel nanowire technology to sample the interstitial fluid from just underneath the skin and then uses an electrochemical reaction to measure either glucose or alcohol concentration. The participants' interstitial alcohol concentration (IAC) will be measured via LabPatch-alcohol at the same time points as blood samples so that a direct comparison can be made. Thus, the LabPatch-alcohol will be tested as the participant's BAC rises and falls through the legally intoxicated concentration (0.08%), and the goal is to match measures obtained via the prototype LabPatch-alcohol with whole blood alcohol concentrations. The LabPatch operational circuit lies on the underside of the bandage. The circuit surface is placed in contact with the skin by the application of the elastic adhesive bandage with a contact tension that provides modest pressure, as in the case of a conventional wound bandage. The temperature of the skin is measured electrically and the consistency of temperature is used to verify good contact and to monitor continued contact. The entire process takes 3-5 seconds to collect the sample, a pause for 1 sec and then 3 additional seconds to conduct the analysis.


Recruitment information / eligibility

Status Recruiting
Enrollment 8
Est. completion date April 30, 2024
Est. primary completion date April 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 50 Years
Eligibility Inclusion Criteria: - Subject is capable of understanding and complying with the protocol - Good physical and mental health (normal physical exam, ECG, blood and urine chemistries, including absences of history or laboratory evidence of diabetes) - Body Mass Index between 18-30, inclusive - Age 21-50 years (age will be verified by driver's license or other valid form of identification) - Have used alcohol, on average, between 5-15 drinks per week over the past 6 months. - Have a stable living situation with current postal address Exclusion Criteria: - Meets criteria for current alcohol or substance use disorders (Past alcohol or substance use disorders greater than 3 years ago is acceptable) - Concurrent diagnosis of Axis I disorder - bMaintained on an antipsychotic or antidepressant medication; taking prescription medications except certain short-term anti-fungal agents and some tropical creams for dermal conditions - Heavy alcohol drinkers (greater than 15 drinks per week) - Tobacco use greater than 5 cigarettes per day - History of major head trauma resulting in cognitive impairment or history of seizure disorder - Heavy caffeine use (greater than 500 mg on a regular daily basis) - Subject has active hepatitis and/or aspartate aminotransferase (AST), alanine aminotransferase (ALT) > 3x the upper limit of normal - For female volunteers, a positive pregnancy test

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
LabPatch-alcohol
a wearable, non-invasive biosensor Band-Aid like patch that is designed to detect real-time changes in interstitial alcohol concentrations in human subjects after they have consumed alcohol

Locations

Country Name City State
United States McLean Hospital Belmont Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Mclean Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Interstitial and Blood Alcohol Concentrations Interstitial (from the skin surface) alcohol concentrations will be obtained via the LabPatch band-aid while at the same time blood samples will be collected in an attempt to correlate the two. The LabPatch-alcohol is a completely noninvasive device and the goal is to determine is precision against the gold standard--blood alcohol concentrations. Both samples will be collected at baseline and at 2.5 to 5 minute intervals for up to 2.5 hrs after a 0.9 g/kg dose of alcohol.
See also
  Status Clinical Trial Phase
Terminated NCT04192448 - Men, Mood, and Attention Study: Examination of Alcohol, State Anger, and Emotion Regulation Sexual Aggression N/A
Completed NCT04230460 - Cannabis Impairment Detection Application (CIDA) N/A
Completed NCT00515294 - Acute and Residual Effects of Caffeinated Beer Phase 2
Recruiting NCT05779774 - WayToServePlus: Improving Responsible Alcohol Service Ph II N/A
Completed NCT03449095 - Understanding Alcohol Reward in Social Context N/A
Completed NCT02861807 - Mindfulness-Based Intervention and Transcranial Direct Current Brain Stimulation to Reduce Heavy Drinking N/A
Completed NCT01783223 - Prevalence of Chronic Inebriates to the Emergency Department and Suitability for Sobering House Services
Completed NCT01688245 - A Text Message Behavioral Intervention to Reduce Alcohol Consumption in Young Adults N/A
Completed NCT05028413 - Evaluating Perceived Fitness to Drive While Intoxicated N/A
Not yet recruiting NCT06419647 - Tracking Mood: The Effects of Daily Mood Tracking VAS on Alcohol Consumption in Adult Heavy Drinkers N/A
Active, not recruiting NCT00608686 - Neurosteroids and Acute Alcohol Intoxication in Humans Phase 1
Recruiting NCT05701865 - Biphasic Effects of Acute Alcohol Intoxication on Bystander Intervention N/A
Recruiting NCT05757089 - Efficacy of the Dietary Food Supplement ALCOFILTRUM in Alleviating Alcohol Hangover Symptoms N/A
Recruiting NCT04912492 - Promoting Prosocial Bystander Behavior in Intoxicated Men: Evaluation of RealConsent2.0 N/A
Active, not recruiting NCT04564599 - The Rise of Ride Sharing Companies and Trends in Impaired Driving Accidents
Not yet recruiting NCT04229732 - Trials of Ventilation Assisted Substance Elimination Via the Lung - Ethanol (VASEL - Ethanol) N/A
Recruiting NCT06065657 - Effect of Nutritional Ketosis on Alcohol Metabolism Phase 2/Phase 3
Recruiting NCT04931095 - The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment Phase 1
Active, not recruiting NCT03467191 - Behavioral Alcohol Responses (BAR) Study Early Phase 1
Recruiting NCT06264791 - Stress-motivated Alcohol Use as a Value-based Decision-making Process N/A